HOLX Share Price

Open 46.52 Change Price %
High 46.54 1 Day -0.36 -0.77
Low 45.90 1 Week 1.81 4.08
Close 46.13 1 Month 3.13 7.28
Volume 9669852 1 Year 12.02 35.24
52 Week High 46.80
52 Week Low 32.81
HOLX Important Levels
Resistance 2 46.72
Resistance 1 46.48
Pivot 46.19
Support 1 45.78
Support 2 45.54
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.16 -33.33%
FTR 1.22 8.93%
FTR 1.22 8.93%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
OPXAW 0.12 200.00%
AVEO 1.25 71.23%
LOCM 0.09 50.00%
MYRX 0.09 50.00%
SNCR 16.24 33.33%
QUIK 1.60 31.15%
WRES 0.09 28.57%
IIN 8.35 27.48%
IIN 8.35 27.48%
IIN 8.35 27.48%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
TOPS 0.80 -66.67%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Hologic, Inc. (NASDAQ: HOLX)

HOLX Technical Analysis 5
As on 23rd Jun 2017 HOLX Share Price closed @ 46.13 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 40.42 & Strong Buy for SHORT-TERM with Stoploss of 44.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
HOLX Target for June
1st Target up-side 45.21
2nd Target up-side 46.55
3rd Target up-side 47.88
1st Target down-side 41.41
2nd Target down-side 40.07
3rd Target down-side 38.74
HOLX Other Details
Segment EQ
Market Capital 5513593344.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.hologic.com
HOLX Address
HOLX
35 Crosby Drive
Bedford, MA 01730
United States
Phone: 781-999-7300
HOLX Latest News
Interactive Technical Analysis Chart Hologic, Inc. ( HOLX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Hologic, Inc.
HOLX Business Profile
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women. The Company operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Company sells and services its products through a combination of direct sales and service forces and a network of independent distributors and sales representatives. On August 1, 2012, the Company acquired Gen-Probe Incorporated (Gen-Probe). Gen-Probe is engaged in molecular diagnostics products and services, which are used to diagnose human diseases, screen donated human blood and test transplant compatibility. In March 2013, it announced that it has completed its sale of the LIFECODES business unit to Immucor, Inc.